combination therapy

Research in Review

Maintenance Therapy for MCL Improved by Targeted Drugs

04/10/2017

JCP Editors

Recent advances in targeted therapies have the potential for major impacts on treatment practices for mantle cell lymphoma (MCL), according to a recent review published in Pharmaceuticals...

Recent...

04/10/2017

Journal of Clinical Pathways

Research in Review

Meta-Analysis Reveals Optimal Combination Therapy for Multiple Myeloma

03/24/2017

JCP Editors

A triple-combination treatment strategy is the most effective therapy for patients with relapsed or refractory multiple myeloma, according to a meta-analysis published in the Journal of Clinical Oncology (published...

A...

03/24/2017

Journal of Clinical Pathways

Research in Review

Antiandrogen Therapy Improves Survival After Prostate Cancer Recurrence

02/07/2017

JCP Editors

Radiation therapy plus bicalutamide improves long-term survival for men with recurring prostate cancer after initial surgery, according to a study published in the New England Journal of Medicine...

...

02/07/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Study Identifies Best Therapy Regimens for Patients With NSCLC

02/02/2017

JCP Editors

A new study comparing first-line therapies for patients with advanced non-small cell lung cancer (NSCLC) suggests a survival advantage of one treatment regimen in younger patients, published in the Journal of Managed...

A new...

02/02/2017

Journal of Clinical Pathways

Research in Review

Prophylactic Treatment Reduces Toxicity in HER2+ Breast Cancer

01/11/2017

JCP Editors

Loperamide plus budesonide reduces the rate of toxic effects associated with neratinib for patients with human epidermal growth factor receptor-2 positive (HER2+) breast cancer, according to the results of a trial...

...

01/11/2017

Journal of Clinical Pathways

Research in Review

Reduced Radiation Improves Cure Rates for Oropharyngeal Cancers

12/30/2016

JCP Editors

Patients with human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinomas may have higher chances of being cured if treated with reduced doses of radiation, according to a new study published in the...

...

12/30/2016

Journal of Clinical Pathways

Research in Review

Chemotherapy Regimens Comparable in Efficacy for Treatment of NSCLC

12/20/2016

JCP Editors

Two of the most common chemotherapy regimens may be comparable in terms of efficacy when used in combination with radiotherapy for treatment of non-small cell lung cancer (NSCLC), according to a recent study...

Two of...

12/20/2016

Journal of Clinical Pathways

Research in Review

Veliparib Effectiveness for NSCLC Linked to Smoking-Related Genetic Signature

12/06/2016

JCP Editors

Tobacco users with non-small cell lung cancer (NSCLC) have genetic alterations in their tumors that may underlie their increased responsiveness to veliparib, according to new research. ----- Related...

...

12/06/2016

Journal of Clinical Pathways

Research in Review

Surgery Plus Chemoradiotherapy Better for Patients With Rectal Cancer

10/25/2016

JCP Editors

Patients with stage II or stage III rectal cancer may have better outcomes when treated with surgery and chemoradiotherapy than those who receive chemoradiotherapy alone, according to an article published in JAMA...

...

10/25/2016

Journal of Clinical Pathways

Research in Review

Treatment With Chemotherapy Drives Urothelial Cancer Resistance

10/21/2016

JCP Editors

Most patients with metastatic urothelial cancer will become resistant to therapy. New research published in Nature Genetics showed that chemotherapy also shapes the genetic evolution of remaining urothelial cancer...

Most...

10/21/2016

Journal of Clinical Pathways